Drug-induced changes in brain tyrosine hydroxylase activity in vivo.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001921:Brain / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D018492:Dopamine Antagonists; D010134:Fenclonine / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D018492:Dopamine Antagonists; D008781:Methyltyrosines; D011941:Receptors, Adrenergic; D011954:Receptors, Dopamine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D014446:Tyrosine 3-Monooxygenase; D010134:Fenclonine